Literature DB >> 28606488

Illness perceptions in patients with heart failure and an implantable cardioverter defibrillator: Dimensional structure, validity, and correlates of the brief illness perception questionnaire in Dutch, French and German patients.

I Timmermans1, H Versteeg2, M Meine3, S S Pedersen4, J Denollet5.   

Abstract

BACKGROUND: Patients' illness perceptions are associated with psychological wellbeing and can be measured with the Brief Illness Perception Questionnaire (B-IPQ). However, little is known about illness perceptions in patients with heart failure. We examined the dimensional structure, validity and clinical and psychological correlates of the B-IPQ in Dutch, French and German patients with heart failure and an implantable cardioverter defibrillator (ICD).
METHOD: European heart failure patients (n=585) participating in the REMOTE-CIED study completed a set of questionnaires 1-2weeks post ICD-implantation, including the B-IPQ. Information on clinical data was captured from patients' medical records.
RESULTS: A two-factor structure (I='Consequences'; II='Control') represented 7 out of 8 B-IPQ items in the total sample and Dutch, German and French subgroups. The total B-IPQ had a Cronbach's α of 0.69, with the 'Consequences' subscale being more internally consistent (α=0.80). Both the B-IPQ and its 'Consequences' subscale were significantly correlated with a number of psychological characteristics, but not with clinical characteristics. Multivariable logistic regression analysis indicated that threatening illness perceptions as measured with the total B-IPQ were associated with poor health status (OR=2.66, 95%CI=1.72-4.11), anxiety (OR=1.79, 95%CI=1.001-3.19), depression (OR=2.81, 95%CI=1.65-4.77), negative affectivity (OR=1.93, 95%CI=1.21-3.09) and poor ICD acceptance (OR=2.68, 95%CI=1.70-4.22).
CONCLUSION: The B-IPQ demonstrated good psychometric properties in Dutch, French and German patients with heart failure. Psychological factors were the most important correlates of patients' perceptions of heart failure, emphasizing the importance of targeting maladaptive illness perceptions in this population, due to their impact on patients' wellbeing and quality of life.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dimensional structure; Heart failure; Illness perceptions; Implantable cardioverter defibrillator; Psychometric properties

Mesh:

Year:  2017        PMID: 28606488     DOI: 10.1016/j.jpsychores.2017.03.014

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  9 in total

1.  An Evaluation of the Association between Quality of Life and Psychological Issues in Patients with Automated Implantable Cardioverter Defibrillator.

Authors:  Nilofar Pasyar; Masoume Rambod; Mohammad Hossein Nikoo; Parisa Mansouri
Journal:  J Caring Sci       Date:  2021-11-06

2.  Perceived control and health-related quality of life in heart transplant recipients.

Authors:  Lynn V Doering; Belinda Chen; Mario Deng; Donna Mancini; Jon Kobashigawa; Kathleen Hickey
Journal:  Eur J Cardiovasc Nurs       Date:  2017-12-20       Impact factor: 3.908

3.  Associations between understanding of current treatment intent, communication with healthcare providers, preferences for invasive life-sustaining interventions and decisional conflict: results from a survey of patients with advanced heart failure in Singapore.

Authors:  Chetna Malhotra; David Sim; Fazlur Jaufeerally; Eric A Finkelstein
Journal:  BMJ Open       Date:  2018-09-19       Impact factor: 2.692

4.  Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow-up.

Authors:  Ivy Timmermans; Mathias Meine; Istvan Szendey; Johannes Aring; Javier Romero Roldán; Lieselotte van Erven; Philipp Kahlert; Edgar Zitron; Philippe Mabo; Johan Denollet; Henneke Versteeg
Journal:  Pacing Clin Electrophysiol       Date:  2019-01-02       Impact factor: 1.976

5.  Heart in art: cardiovascular diseases in novels, films, and paintings.

Authors:  Ad A Kaptein; Pim B van der Meer; Barend W Florijn; Alexander D Hilt; Michael Murray; Martin J Schalij
Journal:  Philos Ethics Humanit Med       Date:  2020-02-13       Impact factor: 2.464

6.  Effect of remote monitoring on clinical outcomes in European heart failure patients with an implantable cardioverter-defibrillator: secondary results of the REMOTE-CIED randomized trial.

Authors:  Cheyenne S L Chiu; Ivy Timmermans; Henneke Versteeg; Edgar Zitron; Philippe Mabo; Susanne S Pedersen; Mathias Meine
Journal:  Europace       Date:  2022-02-02       Impact factor: 5.214

7.  Interdisciplinary and cross-sectoral perioperative care model in cardiac surgery: implementation in the setting of minimally invasive heart valve surgery (INCREASE)-study protocol for a randomized controlled trial.

Authors:  Susanne G R Klotz; Gesche Ketels; Christian A Behrendt; Hans-Helmut König; Sebastian Kohlmann; Bernd Löwe; Johannes Petersen; Sina Stock; Eik Vettorazzi; Antonia Zapf; Inke Zastrow; Christian Zöllner; Hermann Reichenspurner; Evaldas Girdauskas
Journal:  Trials       Date:  2022-06-23       Impact factor: 2.728

8.  Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial.

Authors:  Susanne S Pedersen; Søren J Skovbakke; Uffe K Wiil; Thomas Schmidt; Rene dePont Christensen; Carl J Brandt; Jan Sørensen; Michael Vinther; Charlotte E Larroudé; Thomas M Melchior; Sam Riahi; Kim G E Smolderen; John A Spertus; Jens B Johansen; Jens C Nielsen
Journal:  BMC Cardiovasc Disord       Date:  2018-07-03       Impact factor: 2.298

9.  The effect of psychoeducational intervention, based on a self-regulation model on menstrual distress in adolescents: a protocol of a randomized controlled trial.

Authors:  Somayeh Asgari; Zainab Alimoardi; Mohammad Ali Soleimani; Kelly-Ann Allen; Nasim Bahrami
Journal:  Trials       Date:  2020-08-27       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.